Ticker League

Regeneron Pharmaceuticals (REGN) Income Statement Waterfall

Follow every dollar of Regeneron Pharmaceuticals's revenue down to net income — how much COGS, OpEx, and taxes each consume, and the margin that survives at every step.

Revenue

$14.92B

Gross Margin

+84.5%

Operating Margin

+24.3%

Net Margin

+29.6%

Income statement waterfall for Regeneron Pharmaceuticals (REGN) — TTM through Q1 2026

Net income: $4.42B

Margin breakdown for Regeneron Pharmaceuticals (REGN) — TTM through Q1 2026

  • Revenue$14.92B
  • Cost of Revenue−$2.31B
  • Gross Profit$12.61B
  • Operating Expenses−$8.98B
  • Operating Income$3.63B
  • Other Income / Expense$1.53B
  • Pre-tax Income$5.16B
  • Income Tax−$733.50M
  • Net Income$4.42B
Want to see what changed vs last year?Profit Bridge

Frequently asked questions

Data & methodology